Austrian Left Atrial Appendage Closure Registry

ConditionsAtrial Fibrillation Left Atrial Appendage Closure

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorMedical University of Graz

About this trial

Left atrial appendage (LAA) occlusion (LAAC) has been introduced to treat patients with indication of oral anticoagulation (OAC) for atrial fibrillation (AF) with contraindication to OAC. This registry aims to document all LAAC procedures in Austria.

Eligibility criteria

Qualifiers

Patients who received LAAC in Austria

Disqualifiers

Absence of informed consent

Trial design

Treatments tested in this trial

LAAC

Treatment groups

No treatment groups listed

Locations

Medical University of Graz8036, Graz Austria

Sponsors and collaborators

Medical University of Graz

Lead sponsor

Source ClinicalTrials.gov